Human plasma‐derived alpha(1)‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study

por Lagarde, William H., Courtney, Kecia L., Reiner, Barry, Steinmann, Kimberly, Tsalikian, Eva, Willi, Steven M.
Publicado 2020